Targeted chemo trial offers hope for Tough-to-Treat metastatic cancers
NCT ID NCT06630416
Summary
This study is testing whether the chemotherapy drug pemetrexed works better for people with advanced cancers that have spread and carry specific genetic mutations. It will enroll 64 adults with metastatic bladder cancer or other solid tumors who have already tried other treatments. The main goal is to see if the tumor shrinks in response to the drug and to monitor how long the benefit lasts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV BLADDER CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northwestern Medicine Orland Park
RECRUITINGOrland Park, Illinois, 60462, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.